microdosing glp-1 agonists Medications What Is Microdosing GLP-1s, and
Description
These findings align with prior randomized trials and meta-analyses suggesting class-level cardiovascular benefit
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health care spending.
Read more about the new GLP-1 pill that outperformed oral semaglutide in a recent Phase III trial.
Prime Therapeutics conducted a two-year, real-world study to examine the clinical outcomes and cost when patients were using a GLP-1 drug for obesity treatment.
Learn how retatrutide, a triplereceptor weightloss drug in clinical trials, works on GLP1, GIP, and glucagonand what early research shows.
